Quarterly report · Q3
4937.TEDINET S100ROVI
Period2022-10-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks10 of 10 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.3bn | 2022-10-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Operating income | ¥258m | 2022-10-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥267m | 2022-10-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥22m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥67m | 2022-10-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥62m | 2022-10-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥57m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥62m | 2022-10-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥1.4bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2022-09-30 | Cons. | Assets |
| Total liabilities | ¥638m | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥821m | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥806m | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥743m | at 2022-09-30 | Cons. | Net assets |
| Cash and deposits | ¥1.2bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥906m | at 2022-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥20.72 | 2022-10-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.52 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-19.04 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥20.49 | 2022-10-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 55.8% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Revenue | ¥2.0bn | 2021-10-01 → 2022-06-30 | Standalone | Net sales (5-year summary) |
| Ordinary income | −¥11m | 2021-10-01 → 2022-06-30 | Standalone | Ordinary income loss (5-year summary) |
| Net income | −¥27m | 2021-10-01 → 2022-06-30 | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.7bn | at 2022-06-30 | Standalone | Total assets (5-year summary) |
| Net assets / equity | ¥773m | at 2022-06-30 | Standalone | Net assets (5-year summary) |
| EPS (basic) | ¥-8.87 | 2021-10-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.86 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 45.6% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 14
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-06-30 | −¥271m |
| jpcrp040300-q3r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2022-10-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2022-10-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E36697-000Direct To Consumer Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-06-30 | ¥1m |
| jpcrp040300-q3r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2022-10-01 → 2023-06-30 | ¥557m |
| jpcrp040300-q3r_E36697-000Medical Supportreportable segment | revenue | 2022-10-01 → 2023-06-30 | ¥104m |
| jpcrp040300-q3r_E36697-000Medical Supportreportable segment | revenue external | 2022-10-01 → 2023-06-30 | ¥104m |
| jpcrp040300-q3r_E36697-000Medical Supportreportable segment | segment profit | 2022-10-01 → 2023-06-30 | −¥28m |
| —segment total | revenue | 2022-10-01 → 2023-06-30 | ¥1.3bn |
| —segment total | revenue external | 2022-10-01 → 2023-06-30 | ¥1.3bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-06-30 | ¥1m |
| —segment total | segment profit | 2022-10-01 → 2023-06-30 | ¥529m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 236
| Item | Context | Value | Unit |
|---|---|---|---|
| Retained earnings | Prior1YearInstant | -393652000 | JPY |
| Retained earnings | CurrentQuarterInstant | -331369000 | JPY |
| Shareholders equity | Prior1YearInstant | 742476000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 806009000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 57000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 56000 | JPY |
| Net assets | Prior1YearInstant | 742533000 | JPY |
| Net assets | CurrentQuarterInstant | 806065000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 1563162000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 1444330000 | JPY |
| Net sales | CurrentYTDDuration | 1322397000 | JPY |
| Cost of sales | CurrentYTDDuration | 307143000 | JPY |
| Gross profit | CurrentYTDDuration | 1015253000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 757374000 | JPY |
| Operating income | CurrentYTDDuration | 257879000 | JPY |
| Interest income noi | CurrentYTDDuration | 1171000 | JPY |
| Gain on bad debts recovered noi | CurrentYTDDuration | 11100000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 173000 | JPY |
| Non operating income | CurrentYTDDuration | 12445000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 2367000 | JPY |
| Taxes and dues noe | CurrentYTDDuration | 602000 | JPY |
| Non operating expenses | CurrentYTDDuration | 2970000 | JPY |
| Ordinary income | CurrentYTDDuration | 267354000 | JPY |
| Provision of allowance for doubtful accounts el | CurrentYTDDuration | 200000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 200000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 67354000 | JPY |
| Income taxes current | CurrentYTDDuration | 5072000 | JPY |
| Income taxes | CurrentYTDDuration | 5072000 | JPY |
| Profit loss | CurrentYTDDuration | 62282000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 62282000 | JPY |
| Profit loss | CurrentYTDDuration | 62282000 | JPY |
| Comprehensive income | CurrentYTDDuration | 62282000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 62282000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E36697-000DirectToConsumerBusinessReportableSegmentMember | 1218252000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E36697-000MedicalSupportReportableSegmentMember | 104145000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 1322397000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 1322397000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E36697-000DirectToConsumerBusinessReportableSegmentMember | 1159000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E36697-000MedicalSupportReportableSegmentMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 1159000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -1159000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E36697-000DirectToConsumerBusinessReportableSegmentMember | 1219411000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E36697-000MedicalSupportReportableSegmentMember | 104145000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 1323556000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -1159000 | JPY |
| Net sales | CurrentYTDDuration | 1322397000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E36697-000DirectToConsumerBusinessReportableSegmentMember | 556504000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E36697-000MedicalSupportReportableSegmentMember | -27810000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |